The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2026
Filed:
Jul. 03, 2019
Applicants:
University College Cardiff Consultants Ltd, Cardiff, GB;
University of Birmingham, Birmingham, GB;
Inventors:
Youcef Mehellou, Cardiff, GB;
Benjamin Willcox, Birmingham, GB;
Assignees:
University College Cardiff Consultants Ltd, Cardiff, GB;
University of Birmingham, Birmingham, GB;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07F 9/44 (2006.01); A61K 40/11 (2025.01); A61K 40/42 (2025.01); A61P 19/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/04 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
C07F 9/4465 (2013.01); A61K 40/11 (2025.01); A61K 40/42 (2025.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); C12N 5/0636 (2013.01); C12N 2501/999 (2013.01);
Abstract
The invention relates to a compound of General Formula (I): wherein R1, R2, R3, R4 and R5 are as defined herein. Compounds and compositions comprising the same exhibit high serum stability and potent activation of the γδ T-cell immune response, so are suitable for use in immunotherapy. The invention also relates to methods of immunotherapy using the compounds of General Formula (I).